In March 2025, the company introduced new strategies for a direct-to-buyer offering of its Wegovy weight loss drug. The company set up a new pharmacy, identified as NovoCare, which might cost buyers $499 each month for access to the drug, a lot less than 50 % the expense of the drug by way of other pharmaceutical distribution networks.[53]Comprehen